INDIAN BIOPHARMA HITSRS 25,000 CRORE RIDING 15% GROWTH WAVE
The Indian Biopharma Industry, with over 300 companies, is growing at the rate of 15 per cent, which is 3 percent more than the previous year’s12 per cent. This growth was largely driven by over 20 per cent growth rate recorded by 8 of the top 20companies in the biopharma space.As a result, the Indian Biopharma Industry has crossed the Rs 25,000crore mark for the year 2019-20over the previous year’s figureof Rs 22,124 crore. In 2017-18 theindustry recorded a revenue of Rs18,290 crore. The Indian Biopharma Industry, comprising hormones,insulin, blood products and vaccines recorded a sales revenue of Rs25,442 crore for the year 2019-20.
